Skip to Content

B 417 (Mephobarbital 50 mg)

Pill with imprint B 417 is White, Round and has been identified as Mephobarbital 50 mg. It is supplied by Breckenridge Pharmaceutical Inc.

Mephobarbital is used in the treatment of sedation; epilepsy; seizure prevention and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Mephobarbital 50 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for B 417

Mephobarbital 50 mg B 417

Mephobarbital

Imprint:: B 417
Strength:: 50 mg
Color:: White
Shape:: Round
Availability:: Prescription only
Drug Class:: Barbiturate anticonvulsants
Barbiturates
Pregnancy Category:: D - Positive evidence of risk
CSA Schedule:: 4 - Some potential for abuse
Labeler / Supplier:: Breckenridge Pharmaceutical Inc

More Info Imprint Search Print

Get help with Imprint Code FAQs.

More about mephobarbital

Professional resources

Mephobarbital (FDA)

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Aug 2nd, 2018), Cerner Multum™ (updated Aug 6th, 2018), Wolters Kluwer™ (updated Aug 3rd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.